Synthesis 2009(20): 3391-3398  
DOI: 10.1055/s-0029-1216986
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

An Efficient Hemisynthesis of 20- and 21-[¹³C]-Labeled Cortexolone: A Model for the Study of Skin Sensitization to Corticosteroids

Emilie Claudel, Cécile Arbez-Gindre, Valérie Berl, Jean-Pierre Lepoittevin*
Institut de Chimie, Laboratoire de Dermatochimie, UMR 7177, CNRS et Université de Strasbourg, 4, rue Blaise Pascal, 67070 Strasbourg, France
Fax: +33(3)68851527; e-Mail: jplepoit@unistra.fr;
Further Information

Publication History

Received 15 May 2009
Publication Date:
03 September 2009 (online)

Abstract

A method is described for the synthesis of isotopomers of cortexolone from the commercially available andros-4-ene-3,17-dione. The strategy is based on the use of K¹³CN for labeling at position 20 and of ¹³CH3MgI, generated in situ, for labeling at position 21. Because of the early introduction of the [¹³C] labeling, our efforts aimed at reproducible experimental procedures giving high yields with respect to the isotope containing precursors. During the development of this hemisynthesis, we noted that judicious choice of protective groups was essential as this could lead not only to mixtures or unstable intermediates but also influence considerably the output of reactions.

    References

  • 1 Schimmer BP. Parker KL. In Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 11th ed.   Brunton LL. Lazo JS. Parker KL. McGraw Hill; New York: 2006.  p.1587-1612  
  • 2a Wilkinson SM. Cartwright PH. English JSC. Lancet  1991,  337:  761 
  • 2b Lauerma AI. Contact Dermatitis  1991,  24:  123 
  • 2c Dooms-Goossens A. Morren M. Contact Dermatitis  1992,  26:  182 
  • 2d Matura M. Goossens A. Allergy  2000,  55:  698 
  • 2e Hennge UR. Ruzicka T. Schwartz RA. Cork MJ. J. Am. Acad. Dermatol.  2006,  54:  1 
  • 3a Lepoittevin J.-P. Drieghes J. Goossens A. Arch Dermatol.  1995,  131:  31 
  • 3b Bircher AJ. Thürlimann W. Hunziker Th. Pasche-Koo F. Hunziker N. Perrenoud D. Elsner P. Schultheiss R. Dermatology  1995,  191:  109 ; the author list also includes members of the Swiss contact dermatitis research group
  • 3c Isaksson M. Andersen KE. Brandão FM. Bruynzeel DP. Bruze M. Camarasa JG. Diepgen T. Ducombs G. Frosch PJ. Goossens A. Lahti A. Menné T. Rycroft RJG. Seidenari S. Shaw S. Tosti A. Wahlberg JE. White IR. Wilkinson JD. Contact Dermatitis  2000,  42:  27 
  • 4 Rustemeyer T. van Hoogstraten IMW. von Blomberg BME. Scheper RJ. In Textbook of Contact Dermatitis   Rycroft RJG. Menné T. Frosch PJ. Lepoittevin J.-P. Springer-Verlag; Berlin: 2001.  p.13-58  
  • 5 Lepoittevin J.-P. In Textbook of Contact Dermatitis   Rycroft RJG. Menné T. Frosch PJ. Lepoittevin J.-P. Springer-Verlag; Berlin: 2001.  p.59-89  
  • 6a Bundgaard H. Arch. Pharm. Chem., Sci. Ed.  1980,  8:  83 
  • 6b Matura M. Lepoittevin J.-P. Arbez-Gindre C. Goossens A. Contact Dermatitis  1998,  38:  106 
  • 7a Demoulin JD. Armbruster A.-M. Pullman B. J. Quantum Chem.  1979,  16:  631 
  • 7b Lo TWC. Westwood ME. McLellan AC. Selwood T. Thornalley PJ. J. Biol. Chem.  1994,  269:  32299 
  • 7c Wilkinson SM. Jones MF. Br. J. Dermatol.  1996,  165:  225 
  • 8a Franot C. Benezra C. Lepoittevin J.-P. Bioorg. Med. Chem.  1993,  1:  389 
  • 8b Goetz G. Meschkat E. Lepoittevin J.-P. Bioorg. Med. Chem. Lett.  1999,  9:  1141 
  • 9 Patchett AA. In Biographical Memoirs, National Academy of Sciences   Vol. 81:  The National Academy Press; Washington: 2002.  p.278-293  
  • 10a Andrews DR. Giusto RA. Sudhakar AR. Tetrahedron Lett.  1996,  37:  3417 
  • 10b Batist JNM, Marx AF, van Zoest WJ, and Kapur JC. inventors; European Patent, EP  0263569.  ; Chem. Abstr. 1988, 109, 129460
  • 10c Barton DHR. Motherwell WB. Zard SZ. J. Chem. Soc., Chem. Commun.  1981,  774 
  • 10d Daniewski AR. Wojciechowska W. Synthesis  1984,  132 
  • 10e Murahashi S.-I. Saito TS. Hanaoka H. Murakami Y. Naota T. Kumobayashi H. Akutagawa S. J. Org. Chem.  1993,  58:  2929 
  • 10f Lett R, and Melnyk O. inventors; US Patent, US  5723638.  ; Chem. Abstr. 1996, 124, 176619
  • 11a Horiguchi Y. Nakamura E. Kuwajima I. Org. Synth.  1995,  73:  123 
  • 11b Batist JNM. Barendse NCME. Marx AF. Steroids  1990,  55:  109 
  • 11c VanRheenen VH. inventors; US Patent, US  4500461.  ; Chem. Abstr. 1985, 103, 22844
  • 11d Livingston DA. Petre JE. Bergh CL. J. Am. Chem. Soc.  1990,  112:  6449 
  • 11e Reid JG. Debiak-Krook T. Tetrahedron Lett.  1990,  31:  3669 
  • 11f VanRheenen VH. inventors; European Patent, EP  0153001.  ; Chem. Abstr. 1986, 105, 60816
  • 11g Carruthers NI. Andrews DR. Garshasb S. Giusto RA. J. Chem. Soc., Perkin Trans. 1  1992,  1195 
  • 11h Nitta I. Fujimori S. Ueno H. Bull. Chem. Soc. Jpn.  1985,  58:  978 
  • 11i Carruthers NI. Garshasb S. J. Org. Chem.  1992,  57:  961 
  • 12a Dauben HJ. Löken B. Ringold HJ. J. Am. Chem. Soc.  1954,  76:  1359 
  • 12b Nitz TJ. Paquette LA. Tetrahedron Lett.  1984,  25:  3047 
  • 13a Jackson WR. Jacobs HA. Jayatilake GS. Matthews BR. Watson KG. Aust. J. Chem.  1990,  43:  2045 
  • 13b Luly JR. Hsiao CN. BaMaung N. Plattner JJ. J. Org. Chem.  1988,  53:  6109 
  • 14 Arbez-Gindre C. Berl V. Lepoittevin J.-P. Chem. Commun.  1999,  431 
  • 15 Moriarty RM. John LS. Du PC. J. Chem. Soc., Chem. Commun.  1981,  641 
  • 16 Moriarty RM. J. Org. Chem.  2005,  70:  2893 
  • 17a Ringold HJ. Stork G. J. Am. Chem. Soc.  1958,  80:  250 
  • 17b Ringold HJ. Perez Ruelas J. Batres E. Djerassi C. J. Am. Chem. Soc.  1959,  81:  3712 
  • 17c Rothman ES. Perlstein T. Wall ME. J. Org. Chem.  1960,  25:  1966 
  • 17d Nitta I. Fujimori S. Ueno H. Bull. Chem. Soc. Jpn.  1985,  58:  978 
  • 18 Moreland WT. J. Org. Chem.  1956,  21:  820 
  • 20 Bodor N. Fey L. Kircz M. Hodosan F. Rev. Roum. Chim.  1964,  9:  147 ; Chem. Abstr. 1964, 61, 61819
  • 21a Gadsby B, and Leeming MRG. inventors; US Patent, US  3646012.  ; Chem. Abstr. 1969, 71, 81648
  • 21b Bradford HW. inventors; US Patent, US  3444160.  ; Chem. Abstr. 1969, 71, 61687
  • 22 Numazawa M. Nagaoka M. J. Org. Chem.  1985,  50:  81 
  • 23 Julian PL. Meyer EW. Ryden I. J. Am. Chem. Soc.  1950,  72:  367 
  • 24 Ringold HJ. Rosenkranz G. Sondheimer F. J. Am. Chem. Soc.  1956,  78:  820 
19

THF containing a certain amount of peroxide (titration with KI and thiosulfate) was prepared as follows: In a typical procedure, THF was exposed to sunlight in an open bottle until the peroxide content reached the expected value. Alternatively, THF could be first distilled from CaO before exposure to sunlight. Fresh and aged THF may be combined to give the proper peroxide content.